ImmuCell Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.86	3.81	3.76	0.98	5.79	10.19
Cash & Short-Term Investments	8.86	3.81	3.76	0.98	5.79	10.19
Cash Growth	47.71%	1.29%	283.99%	-83.10%	-43.14%	28.18%
Accounts Receivable	2.9	3.42	3.77	2.19	1.76	2.69
Inventory	9.08	9.27	7.11	7.81	6.04	3.09
Other Current Assets	0.24	0.45	0.4	0.49	0.41	0.3
Total Current Assets	21.08	16.94	15.04	11.47	13.99	16.26
Net Property, Plant & Equipment	25.42	25.45	29.91	32.15	30.64	28
Other Intangible Assets	-	-	0.02	0.04	0.06	0.08
Goodwill	0.1	0.1	0.1	0.1	0.1	0.1
Other Long-Term Assets	0.03	0.04	0.03	0.06	0.08	0.03
Total Assets	46.63	42.53	45.1	43.81	44.86	44.47
Accounts Payable	2.81	2.28	2.48	2.12	2	1.61
Current Portion of Long-Term Debt	1.51	1.61	1.5	1.43	1.04	0.81
Current Portion of Leases	0.12	0.09	0.43	0.64	0.03	0.11
Total Current Liabilities	4.44	3.98	4.41	4.2	3.07	2.53
Long-Term Debt	6.8	7.49	9.04	10.54	9.19	8.33
Long-Term Leases	4.02	4.01	4.13	4.08	2.22	1.03
Total Long-Term Liabilities	10.82	11.5	13.17	14.62	11.41	9.35
Total Liabilities	15.26	15.48	17.58	18.82	14.48	11.89
Common Stock	0.91	0.91	0.9	0.78	0.78	0.78
Treasury Stock	-0.08	-0.13	-0.14	-0.14	-0.15	-0.16
Additional Paid-in Capital	41.97	41.48	40.92	36.36	35.98	35.69
Retained Earnings	-11.43	-15.2	-14.16	-12.01	-6.23	-3.74
Shareholders' Equity	31.37	27.06	27.52	24.99	30.38	32.58
Total Liabilities & Equity	46.63	42.53	45.1	43.81	44.86	44.47
Total Debt	12.45	13.19	15.1	16.69	12.48	10.27
Net Cash (Debt)	-3.59	-9.39	-11.34	-15.71	-6.69	-0.09
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.40	-1.04	-1.39	-2.03	-0.86	-0.01
Book Value	31.37	27.06	27.52	24.99	30.38	32.58
Book Value Per Share	3.45	3.00	3.37	3.23	3.92	4.29
Tangible Book Value	31.28	26.96	27.4	24.86	30.23	32.4
Tangible Book Value Per Share	3.44	2.99	3.36	3.21	3.90	4.27

SEC Filings: 10-K · 10-Q